Top Banner
UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009
48

UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Dec 30, 2015

Download

Documents

Ilene Pearson
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

UVEA Rounds

Crissa Marie A. Gay-ya, MDApril 27, 2009

Page 2: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Case

• A.D.

• 38/M

• Seaman

• Right eye pain

Page 3: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

HPI

• Recurrent uveitis – 2001, right eye– 2003, left eye– 2005, left eye– 2007, right eye

– Intra-ocular steroids– Prednisolone acetate eye drops, 2 drops 4 x a day

Page 4: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

5 days PTC eye pain, right

(+) redness, tearing, and

blurring of vision, right

ER consult

Page 5: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Ocular Exam

SC PH AT

OD 20/20 -2 NI 15

OS 20/20 15

Page 6: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.
Page 7: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

AC deepAC deep

Page 8: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• Fundoscopy:– OD:

• (+) ROR, CM, DDB, CDR 0.3, AVR 2:3, (-) h/e

– OS:• (+) ROR, CM, DDB, CDR 0.3, AVR 2:3, (-) h/e

Page 9: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

ER Diagnosis and Plan

• Anterior uveitis, right

• Ibuprofen 400mg BID

• Tobramycin 1gtt QID, OD

• Tropicamide 1gtt TID, OD

• Refer to Uvea Clinic

Page 10: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Uvea Clinic

• Slight improvement of eye pain

• Past Medical History– No hypertension or DM– With scoliosis (?)– With hemorrhoids

• Family History– No heredofamilial disease

Page 11: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Review of Systems

• No fever, no loss of appetite

• No headache, no tinnitus

• No difficulty of breathing, no cough

• No chest pain, no palpitations

• With changes in bowel movement

Page 12: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• No changes in urination, no genital ulcers

• With back pains, no joint pains

• No easy bruising

• No polydypsia, polyphagia, polyuria

• No loss of consiousness, no seizures

Page 13: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Ocular Exam

SC PH AT

OD 20/40 20/20 20

OS 20/32 20

Page 14: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

No RAPD(+) Gross Color Perception

Page 15: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Shallowing of ACShallowing of AC

Page 16: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• Fundoscopy:– OD:

• (+) ROR, CM, DDB, CDR 0.3, AVR 2:3, (-) h/e

– OS:• (+) ROR, CM, DDB, CDR 0.3, AVR 2:3, (-) h/e

Page 17: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Salient Features

• 38/M• Recurrent uveitis, both eyes• Eye pain, redness, BOV, • Conjunctivits, iritis, posterior synechiae• Shallowing of AC• Back pain • No joint pains• No genitourinary symptoms

Page 18: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Uvea Diagnosis and Plan

• t/c Ankylosing Spondylitis• Meds:

– Prednisolone acetate 1gtt q 1, OD– Methylprednisolone 40mg/ml, transeptal, OD

• Labs:– RF– ANA– HLA B-27– Sacroiliac x-ray– CXR– PPR– ESR– CBC with platelet

Page 19: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Sadly, the patient was lost to follow-up.

Page 20: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

HLA-B27-Associated Anterior Uveitis with Systemic Disease

• Ankylosing spondylitis• Reitier’s syndrome• Inflammatory bowel disease• Psoriatic arthritis• Post-infectious arhtritis

Page 21: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• Incidence

• Role of HLA-B27

• Ocular and Systemic manifestations

• Treatment

Page 22: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Ankylosing Spondylitis: Incidence

• 2.5 to 3 Male: 1 Female

• Females have milder disease

• 96% have (+) HLA-B27

• Only 1.3% of all HLA-B27-positive patients develop the disease

Page 23: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Ankylosing Spondylitis: HLA-B27

• No clear association

• Infection with gram negative bacteria

• Theories on HLA-B27:1. Receptor for infectious agent

2. Cross-react with foreign antigens

3. Marker for immune response gene

Page 24: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Ankylosing Spondylitis: Ocular Manifestations

• 25%

• Bilateral in 80%, but rarely simultaneous

• Recurrence

• Iritis

• Conjunctivitis

Page 25: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• Symptoms occur 1-2 days before clinical signs

• Anterior chamber reaction– Blurring of vision– Fibrin clot– Posterior synechiae

Page 26: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• Sacroilitis

Ankylosing Spondylitis: Systemic Manifestations

Page 27: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• Uveitis does not correlate with the severity of the spondylitis

• Aortic insufficiency

• Cardiomegaly

• Conduction defects

Page 28: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• If the disease is recognized and treated early, spinal deformity can be prevented

• Physical therapy

• NSAIDs

Ankylosing Spondylitis: Treatment

Page 29: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Ankylosing Spondylitis

Patient

Male predominance √

HLA-B27 ?

Bilateral √

Recurrence √

Iritis, conjuntivitis √

Symptoms √

Sacroilitis +/-

Page 30: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Reiter’s Syndrome

Page 31: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Reiter’s Syndrome:Incidence

• Most common cause of inflammatory oligoarthropathy in young males

Page 32: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Reiter’s Syndrome:HLA-B27

• 1% with non-specific urethritis – Chlamydia trachomatis– Ureaplasma urealyticum

• 2% dysentery– Shigella, Salmonella, Yersinia– Treatment does not alter the development or

course of the syndrome

Page 33: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Reiter’s Syndrome:Manifestations

Page 35: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Reiter’s Syndrome:Ocular Manifestations

• Conjunctivitis– Mucoid discharge

• Keratitis– Multifocal punctate subepithelial and stromal

infiltrates

• Iritis– Mild, non-granulomatous

Page 36: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Reiter’s Syndrome:Treatment

• Ocular– Topical corticosterooids– Mydriatic agents

• Joint involvement– NSAIDs– Immunosuppresive therapy

Page 37: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Uveitis and spondyloarthritis: prevalence and relationship with

joint diseaseFaculdade Evangélica de Medicina do

Paraná, and Hospital Universitário Evangélico de Curitiba, Curitiba, PR,

Brazil. [email protected]

Page 38: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• PURPOSE: To study uveitis prevalence in the local population with spondyloarthritis and its temporal relationship with joint complaints.

Page 39: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• METHODS: We reviewed seventy-seven charts of spondyloarthropathy patients from the rheumatology clinic of the "Hospital Universitário Evangélico de Curitiba" for spondyloarthritis class, patients' sex and age, occurrence of uveitis and its location and relationship between the first episode of uveitis and initial joint complaints.

Page 40: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• RESULTS: Uveitis was found in 12 of 77 patients (15.6%) which was anterior in 83.3% of the cases, without preference for spondyloarthropathy class (p=0.72) and patients' sex (p=0.74). In patients with reactive arthritis, the mean time between uveitis appearance and joint complaints was 4.04 months and in ankylosing spondylitis 73 months (p=0.009).

Page 41: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• CONCLUSION: Spondyloarthropathy patients have uveitis that is anterior in most of the cases and that appears earlier in reactive arthritis than in ankylosing spondylitis

Page 42: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Ophthalmological involvement in rheumatic disease]

Spitalul Clinic de Urgente Oftalmologice, Bucuresti.

Page 43: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• PURPOSE: The main objective of this study was to identify the prevalence of ocular manifestations in rheumatic patients admitted in a specialized clinic.

Page 44: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• METHODS: Information regarding rheumatic and ocular diseases was extracted from medical records system available in "Dr. I. Cantacuzino" Clinical Hospital from Bucharest. The prevalence of ocular involvement reported passively by rheumatologists (retrospective descriptive study of 375 different cases of rheumatic patients) was compared with the literature data.

Page 45: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• RESULTS: There were 45 cases of ocular manifestations. Keratoconjunctivitis sicca was noted in 16 patients with rheumatoid arthritis, two patients with systemic lupus erythematosus and one patient with scleroderma. Anterior uveitis was found in seven patients with ankylosing spondylitis, one patient with reactive arthritis, two patients with psoriatic arthritis and one patient with LES. Conjunctivitis was present in two patients with reactive arthritis. In LES ocular involvement also included four cases of retinal vasculitis. Complications clearly related to steroid therapy were nine cases of cataracts. One case with typical "bull's eye" maculopathy due to Hydroxychloroquine treatment was detected.

Page 46: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

• CONCLUSIONS: The main conclusion of our study is that the rheumatic patients need to be referred to an ophthalmologist for the diagnosis and the optimal treatment of ocular involvement.

Page 47: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.

Thank you.

Good morning.

Page 48: UVEA Rounds Crissa Marie A. Gay-ya, MD April 27, 2009.